ERBB2 and breast cancer: A specific study explored the potential of miR-98 in predicting Sentinel Lymph Node Metastasis in ER+/HER2-breast cancer, developing a model that showed a significant association between miR-98 and SLNM, however, the direction of miR-98 regulation wasn’t detailed [106].